Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to confirm the clinical efficacy and the safety of P-3074 in participants with androgenetic alopecia.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03004469
Study type Interventional
Source Polichem S.A.
Contact
Status Completed
Phase Phase 3
Start date August 2, 2016
Completion date March 5, 2018

See also
  Status Clinical Trial Phase
Completed NCT01189279 - Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia Phase 1
Completed NCT02503852 - STYLE -- A Trial of Cell Enriched Adipose For Androgenetic Alopecia N/A
Not yet recruiting NCT03154528 - Role of Vitamin D in Androgenetic Alopecia
Terminated NCT02676310 - Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA) Phase 1
Completed NCT01325337 - Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia Phase 2
Not yet recruiting NCT02316418 - Hairstetics™ Anchoring System in Female Pattern Hair Loss (HAS-FPHL) N/A
Completed NCT01904721 - A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA) Phase 2
Recruiting NCT04913519 - A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA) Phase 1